UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.730-738

2016

Volltextzugriff (PDF)

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Blood, 2016-04, Vol.127 (14), p.1761-1769

2016

Volltextzugriff (PDF)

Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery

Thrombosis and haemostasis, 2011-06, Vol.105 (6), p.1072

2011

Volltextzugriff (PDF)

Genomic analyses of withers height and linear conformation traits in German Warmblood horses using imputed sequence-level genotypes

Genetics selection evolution (Paris), 2024-06, Vol.56 (1), p.45-18, Article 45

2024

Volltextzugriff (PDF)

Characterization of a Porcine Model for Von Willebrand Disease Type 1 and 3 Regarding Expression of Angiogenic Mediators in the Nonpregnant Female Reproductive Tract

Comparative medicine, 2019-10, Vol.69 (5), p.401-412

2019

Volltextzugriff (PDF)

Genetic and genomic characterization followed by single-step genomic evaluation of withers height in German Warmblood horses

Journal of applied genetics, 2022-05, Vol.63 (2), p.369-378

2022

Volltextzugriff (PDF)

Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation

Journal of thrombosis and haemostasis, 2005-09, Vol.3 (9), p.1935-1944

2005

Volltextzugriff (PDF)

A 12.3-kb Duplication Within the VWF Gene in Pigs Affected by Von Willebrand Disease Type 3

G3 : genes - genomes - genetics, 2018-02, Vol.8 (2), p.577-585

2018

Volltextzugriff (PDF)

Haemostaseological Changes of VWF and FVIII during Pregnancy and the Oestrus Cycle in a Porcine Model of Von Willebrand Disease

Hemato, 2024-03, Vol.5 (1), p.48-65

2024

Volltextzugriff (PDF)

Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B

TH open : companion journal to thrombosis and haemostasis, 2024-01, Vol.8 (1), p.e155-e163

2024

Volltextzugriff (PDF)

Influence of Von Willebrand Disease (VWD) and pregnancy on the expression of angiogenic factors in the porcine female reproductive tract

Reproductive biology, 2022-12, Vol.22 (4), p.100700, Article 100700

2022

Volltextzugriff (PDF)

Sixth Åland Island Conference on von Willebrand disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-07, Vol.28 (S5), p.3-15

2022

Volltextzugriff (PDF)

Expression of angiogenic factors in the uteroplacental unit is altered at time of placentation in a porcine model of von Willebrand disease type 1

Reproductive biology, 2019-12, Vol.19 (4), p.412-420

2019

Volltextzugriff (PDF)

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Blood, 2012-11, Vol.120 (18), p.3670-3676

2012

Volltextzugriff (PDF)

Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-09, Vol.10 (5), p.499-508

2004

Volltextzugriff (PDF)

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease

TH open : companion journal to thrombosis and haemostasis, 2021-07, Vol.5 (3), p.e264-e272

2021

Volltextzugriff (PDF)

Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters

European journal of pediatrics, 1999-12, Vol.158 Suppl 3 (S3), p.S143-S146

1999

Volltextzugriff (PDF)

Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection

Journal of medical virology, 1996-04, Vol.48 (4), p.339-343

1996

Volltextzugriff (PDF)

Von Willebrand disease type 1 in a porcine model influences expression of integrin αVβ3, members of the VEGF/VEGFR-2 system and ANG/TIE ratios at the time of placentation

Placenta (Eastbourne), 2019-08, Vol.83, p.e18-e18

2019

Volltextzugriff (PDF)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Blood, 2013-01, Vol.121 (3), p.537-545

2013

Volltextzugriff (PDF)

Expression of ECE1, IGFBP7 and CALR in a porcine model for von Willebrand disease (VWD) type 1 and 3

Placenta (Eastbourne), 2019-08, Vol.83, p.e19-e20

2019

Volltextzugriff (PDF)

Von Willebrand Disease influences the expression of angiogenic factors and the blood vessel conformation in the uterus in a porcine model

Placenta (Eastbourne), 2017-09, Vol.57, p.271-272

2017

Volltextzugriff (PDF)

The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention

Haematologica (Roma), 2015-08, Vol.100 (8), p.1038

2015

Volltextzugriff (PDF)

Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry

American journal of clinical pathology, 2001-10, Vol.116 (4), p.567-574

2001

Volltextzugriff (PDF)

Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long‐term data of the SIGNS study

European journal of haematology, 2017-08, Vol.99 (2), p.169-177

2017

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(42)
Buchkapitel
(7)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery

Genomic analyses of withers height and linear conformation traits in German Warmblood horses using imputed sequence-level genotypes

Characterization of a Porcine Model for Von Willebrand Disease Type 1 and 3 Regarding Expression of Angiogenic Mediators in the Nonpregnant Female Reproductive Tract

Genetic and genomic characterization followed by single-step genomic evaluation of withers height in German Warmblood horses

Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation

A 12.3-kb Duplication Within the VWF Gene in Pigs Affected by Von Willebrand Disease Type 3

Haemostaseological Changes of VWF and FVIII during Pregnancy and the Oestrus Cycle in a Porcine Model of Von Willebrand Disease

Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B

Influence of Von Willebrand Disease (VWD) and pregnancy on the expression of angiogenic factors in the porcine female reproductive tract

Sixth Åland Island Conference on von Willebrand disease

Expression of angiogenic factors in the uteroplacental unit is altered at time of placentation in a porcine model of von Willebrand disease type 1

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease

Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters

Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection

Von Willebrand disease type 1 in a porcine model influences expression of integrin αVβ3, members of the VEGF/VEGFR-2 system and ANG/TIE ratios at the time of placentation

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Expression of ECE1, IGFBP7 and CALR in a porcine model for von Willebrand disease (VWD) type 1 and 3

Von Willebrand Disease influences the expression of angiogenic factors and the blood vessel conformation in the uterus in a porcine model

The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention

Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry

Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long‐term data of the SIGNS study

Suchergebnisse filtern